Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Panic, dyspnea, and asthma

J W Smoller1, M W Otto

  • 1Anxiety Disorders Program, Massachusetts General Hospital, Boston 02114, USA.

Current Opinion in Pulmonary Medicine
|April 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The unexpected death of a loved one and risk for onset of PTSD and depression in the Nepal Chitwan Valley Family Study.

Journal of affective disorders·2025
Same author

MIR137 polygenic risk for schizophrenia and ephrin-regulated pathway: Role in lateral ventricles and corpus callosum volume.

International journal of clinical and health psychology : IJCHP·2024
Same author

Prior differences in previous trauma exposure primarily drive the observed racial/ethnic differences in posttrauma depression and anxiety following a recent trauma.

Psychological medicine·2022
Same author

Characterizing sleep spindles in 11,630 individuals from the National Sleep Research Resource.

Nature communications·2017
Same author

Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.

Molecular psychiatry·2017
Same author

Genetic effects influencing risk for major depressive disorder in China and Europe.

Translational psychiatry·2017
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Asthma patients often experience anxiety disorders, complicating diagnosis. Effective anxiety treatment in asthma can improve patient quality of life.

Area of Science:

  • Pulmonary Medicine
  • Psychiatry
  • Clinical Psychology

Background:

  • Dyspnea is a key symptom in both asthma and panic attacks.
  • Asthma patients exhibit high comorbidity with anxiety disorders.
  • Respiratory illness may increase the risk of developing panic disorder.

Purpose of the Study:

  • To explore the relationship between asthma and anxiety disorders.
  • To highlight diagnostic challenges and treatment strategies for anxiety in asthma patients.
  • To emphasize the benefits of managing anxiety in this population.

Main Methods:

  • Literature review of studies on asthma, dyspnea, and anxiety disorders.
  • Analysis of diagnostic considerations for comorbid conditions.
  • Evaluation of evidence-based treatment options for anxiety in asthma.

Related Experiment Videos

Main Results:

  • Anxiety disorders are prevalent in asthma patients.
  • Accurate diagnosis of anxiety is crucial for effective asthma management.
  • Untreated anxiety exacerbates asthma-related morbidity.

Conclusions:

  • Successful identification and treatment of anxiety disorders significantly improve outcomes for asthma patients.
  • Serotonergic anxiolytic medications are recommended treatments.
  • Cognitive-behavioral therapy is a primary therapeutic approach for pathologic anxiety in asthma.